In this May 2025 edition of Yet Another Value Podcast, host Andrew Walker shares a range of thoughts in his monthly solo ramble. He opens with macro commentary on market resilience post-"Liberation Day" and ongoing CEO uncertainty. He transitions to the role of AI in investing, using analogies from sports to explore how AI may alter investor success profiles. Andrew dives into how management teams' sales skills can mislead investors and shares his growing skepticism from biotech engagements. The episode closes with reflections on how personal preferences influence investing decisions and a detailed breakdown of how sunk costs and overhead can erode biotech value.

______________________________________________________________________

[0:00:00] Podcast intro and episode preview.

[0:02:02] Corporate governance discussion overview.

[0:03:22] Host introduction and podcast growth.

[0:04:16] Topics: market, AI, management, products.

[0:05:09] Market reaction since Liberation Day.

[0:07:26] CEO uncertainty and delayed investments.

[0:11:44] Complacency, speculative vs. cyclical sectors.

[0:12:22] AI as knowledge enhancer for investors.

[0:14:01] AI and sports analogies for change.

[0:18:46] AI impacting future investor skillsets.

[0:22:05] Management interviews and AI impact.

[0:25:24] Trusting vs. over-trusting management teams.

[0:31:44] Selling skills of management vs. investors

[0:34:09] Viral products and parsing endorsements.

[0:38:32] Disliking a product but buying stock.

[0:42:20] Balancing personal preferences with investing.

[0:44:00] Management and sunk costs in biotech.

[0:53:44] Overhead expenses distort trial economics.

[0:57:27] Wrap-up: biotech, books, and future episodes.

Links:

Yet Another Value Blog - https://www.yetanothervalueblog.com See our legal disclaimer here: https://www.yetanothervalueblog.com/p/legal-and-disclaimer